Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer

Aman U. Buzdar, S. Eva Singletary, Richard L. Theriault, Daniel J. Booser, Vicente Valero, Nuhad Ibrahim, Terry L. Smith, Lina Asmar, Debra Frye, Nikki Manuel, Shu Wan Kau, Marsha McNeese, Eric Strom, Kelly Hunt, Frederick Ames, Gabriel N. Hortobagyi

Research output: Contribution to journal › Article › peer-review

227 Scopus citations

Fingerprint

Dive into the research topics of 'Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences